(3S,6S,9S,15S,18S,21S,30S,33S,36S,39S,42S,45S,48S,50R)-N,6,15-tris(2-amino-2-oxoethyl)-36-butyl-30-(3-carbamimidamidopropyl)-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-18,19,33,34,37-pentamethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide

C86H121N23O21S — CID 130415746

IUPAC(3S,6S,9S,15S,18S,21S,30S,33S,36S,39S,42S,45S,48S,50R)-N,6,15-tris(2-amino-2-oxoethyl)-36-butyl-30-(3-carbamimidamidopropyl)-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-18,19,33,34,37-pentamethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide
SMILES[H]/N=C(\N)NCCC[C@@H]1NC(=O)[C@H](C)N(C)C(=O)[C@H](CCCC)N(C)C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CSCC(C(=O)NCC(N)=O)NC1=O
InChIInChI=1S/C86H121N23O21S/c1-9-10-22-66-85(130)106(7)46(5)72(117)97-56(21-15-28-92-86(90)91)75(120)104-64(74(119)95-39-70(89)115)42-131-43-71(116)96-60(31-47-24-26-50(111)27-25-47)81(126)105(6)45(4)73(118)100-62(36-69(88)114)83(128)108-29-16-23-65(108)79(124)99-58(35-68(87)113)77(122)101-59(30-44(2)3)84(129)109-40-51(112)34-67(109)80(125)98-57(32-48-37-93-54-19-13-11-17-52(48)54)76(121)103-63(41-110)78(123)102-61(82(127)107(66)8)33-49-38-94-55-20-14-12-18-53(49)55/h11-14,17-20,24-27,37-38,44-46,51,56-67,93-94,110-112H,9-10,15-16,21-23,28-36,39-43H2,1-8H3,(H2,87,113)(H2,88,114)(H2,89,115)(H,95,119)(H,96,116)(H,97,117)(H,98,125)(H,99,124)(H,100,118)(H,101,122)(H,102,123)(H,103,121)(H,104,120)(H4,90,91,92)/t45-,46-,51+,56-,57-,58-,59-,60-,61-,62-,63-,64?,65-,66-,67-/m0/s1
InChIKeyWRSQDZXURDMITO-SDWCODCBSA-N
MW1845.12 g/mol
LogP-5.19
Rot. Bonds23

About (3S,6S,9S,15S,18S,21S,30S,33S,36S,39S,42S,45S,48S,50R)-N,6,15-tris(2-amino-2-oxoethyl)-36-butyl-30-(3-carbamimidamidopropyl)-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-18,19,33,34,37-pentamethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide

(3S,6S,9S,15S,18S,21S,30S,33S,36S,39S,42S,45S,48S,50R)-N,6,15-tris(2-amino-2-oxoethyl)-36-butyl-30-(3-carbamimidamidopropyl)-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-18,19,33,34,37-pentamethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide (PubChem CID 130415746) has the molecular formula C86H121N23O21S and a molecular weight of 1845.12 g/mol. Its IUPAC name is (3S,6S,9S,15S,18S,21S,30S,33S,36S,39S,42S,45S,48S,50R)-N,6,15-tris(2-amino-2-oxoethyl)-36-butyl-30-(3-carbamimidamidopropyl)-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-18,19,33,34,37-pentamethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide.

Molecular Properties

Compound Name(3S,6S,9S,15S,18S,21S,30S,33S,36S,39S,42S,45S,48S,50R)-N,6,15-tris(2-amino-2-oxoethyl)-36-butyl-30-(3-carbamimidamidopropyl)-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-18,19,33,34,37-pentamethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide
PubChem CID130415746
Molecular FormulaC86H121N23O21S
Molecular Weight1845.12 g/mol
Exact Mass1843.88
IUPAC Name(3S,6S,9S,15S,18S,21S,30S,33S,36S,39S,42S,45S,48S,50R)-N,6,15-tris(2-amino-2-oxoethyl)-36-butyl-30-(3-carbamimidamidopropyl)-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-18,19,33,34,37-pentamethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide
SMILES[H]/N=C(\N)NCCC[C@@H]1NC(=O)[C@H](C)N(C)C(=O)[C@H](CCCC)N(C)C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CSCC(C(=O)NCC(N)=O)NC1=O
InChIInChI=1S/C86H121N23O21S/c1-9-10-22-66-85(130)106(7)46(5)72(117)97-56(21-15-28-92-86(90)91)75(120)104-64(74(119)95-39-70(89)115)42-131-43-71(116)96-60(31-47-24-26-50(111)27-25-47)81(126)105(6)45(4)73(118)100-62(36-69(88)114)83(128)108-29-16-23-65(108)79(124)99-58(35-68(87)113)77(122)101-59(30-44(2)3)84(129)109-40-51(112)34-67(109)80(125)98-57(32-48-37-93-54-19-13-11-17-52(48)54)76(121)103-63(41-110)78(123)102-61(82(127)107(66)8)33-49-38-94-55-20-14-12-18-53(49)55/h11-14,17-20,24-27,37-38,44-46,51,56-67,93-94,110-112H,9-10,15-16,21-23,28-36,39-43H2,1-8H3,(H2,87,113)(H2,88,114)(H2,89,115)(H,95,119)(H,96,116)(H,97,117)(H,98,125)(H,99,124)(H,100,118)(H,101,122)(H,102,123)(H,103,121)(H,104,120)(H4,90,91,92)/t45-,46-,51+,56-,57-,58-,59-,60-,61-,62-,63-,64?,65-,66-,67-/m0/s1
InChIKeyWRSQDZXURDMITO-SDWCODCBSA-N
XLogP-5.19
TPSA675.99 Ų
H-Bond Donors21
H-Bond Acceptors23
Rotatable Bonds23
Heavy Atoms131
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001845.12
LogP ≤ 5-5.19
H-Bond Donors ≤ 521
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze (3S,6S,9S,15S,18S,21S,30S,33S,36S,39S,42S,45S,48S,50R)-N,6,15-tris(2-amino-2-oxoethyl)-36-butyl-30-(3-carbamimidamidopropyl)-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-18,19,33,34,37-pentamethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,6S,9S,15S,18S,21S,30S,33S,36S,39S,42S,45S,48S,50R)-N,6,15-tris(2-amino-2-oxoethyl)-36-butyl-30-(3-carbamimidamidopropyl)-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-18,19,33,34,37-pentamethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide?
The IUPAC name of (3S,6S,9S,15S,18S,21S,30S,33S,36S,39S,42S,45S,48S,50R)-N,6,15-tris(2-amino-2-oxoethyl)-36-butyl-30-(3-carbamimidamidopropyl)-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-18,19,33,34,37-pentamethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide (CID 130415746) is (3S,6S,9S,15S,18S,21S,30S,33S,36S,39S,42S,45S,48S,50R)-N,6,15-tris(2-amino-2-oxoethyl)-36-butyl-30-(3-carbamimidamidopropyl)-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-18,19,33,34,37-pentamethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide.
What is the SMILES notation for (3S,6S,9S,15S,18S,21S,30S,33S,36S,39S,42S,45S,48S,50R)-N,6,15-tris(2-amino-2-oxoethyl)-36-butyl-30-(3-carbamimidamidopropyl)-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-18,19,33,34,37-pentamethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide?
The canonical SMILES for (3S,6S,9S,15S,18S,21S,30S,33S,36S,39S,42S,45S,48S,50R)-N,6,15-tris(2-amino-2-oxoethyl)-36-butyl-30-(3-carbamimidamidopropyl)-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-18,19,33,34,37-pentamethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide is [H]/N=C(\N)NCCC[C@@H]1NC(=O)[C@H](C)N(C)C(=O)[C@H](CCCC)N(C)C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CSCC(C(=O)NCC(N)=O)NC1=O.
What is the InChIKey of (3S,6S,9S,15S,18S,21S,30S,33S,36S,39S,42S,45S,48S,50R)-N,6,15-tris(2-amino-2-oxoethyl)-36-butyl-30-(3-carbamimidamidopropyl)-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-18,19,33,34,37-pentamethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide?
The InChIKey is WRSQDZXURDMITO-SDWCODCBSA-N. The full InChI is InChI=1S/C86H121N23O21S/c1-9-10-22-66-85(130)106(7)46(5)72(117)97-56(21-15-28-92-86(90)91)75(120)104-64(74(119)95-39-70(89)115)42-131-43-71(116)96-60(31-47-24-26-50(111)27-25-47)81(126)105(6)45(4)73(118)100-62(36-69(88)114)83(128)108-29-16-23-65(108)79(124)99-58(35-68(87)113)77(122)101-59(30-44(2)3)84(129)109-40-51(112)34-67(109)80(125)98-57(32-48-37-93-54-19-13-11-17-52(48)54)76(121)103-63(41-110)78(123)102-61(82(127)107(66)8)33-49-38-94-55-20-14-12-18-53(49)55/h11-14,17-20,24-27,37-38,44-46,51,56-67,93-94,110-112H,9-10,15-16,21-23,28-36,39-43H2,1-8H3,(H2,87,113)(H2,88,114)(H2,89,115)(H,95,119)(H,96,116)(H,97,117)(H,98,125)(H,99,124)(H,100,118)(H,101,122)(H,102,123)(H,103,121)(H,104,120)(H4,90,91,92)/t45-,46-,51+,56-,57-,58-,59-,60-,61-,62-,63-,64?,65-,66-,67-/m0/s1.
What are the key properties of (3S,6S,9S,15S,18S,21S,30S,33S,36S,39S,42S,45S,48S,50R)-N,6,15-tris(2-amino-2-oxoethyl)-36-butyl-30-(3-carbamimidamidopropyl)-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-18,19,33,34,37-pentamethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide?
(3S,6S,9S,15S,18S,21S,30S,33S,36S,39S,42S,45S,48S,50R)-N,6,15-tris(2-amino-2-oxoethyl)-36-butyl-30-(3-carbamimidamidopropyl)-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-18,19,33,34,37-pentamethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide has a molecular weight of 1845.12 g/mol, XLogP of -5.19, 23 rotatable bonds, 21 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,6S,9S,15S,18S,21S,30S,33S,36S,39S,42S,45S,48S,50R)-N,6,15-tris(2-amino-2-oxoethyl)-36-butyl-30-(3-carbamimidamidopropyl)-50-hydroxy-42-(hydroxymethyl)-21-[(4-hydroxyphenyl)methyl]-39,45-bis(1H-indol-3-ylmethyl)-18,19,33,34,37-pentamethyl-3-(2-methylpropyl)-2,5,8,14,17,20,23,29,32,35,38,41,44,47-tetradecaoxo-25-thia-1,4,7,13,16,19,22,28,31,34,37,40,43,46-tetradecazatricyclo[46.3.0.09,13]henpentacontane-27-carboxamide is sourced from PubChem (CID 130415746), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).